Elevar Therapeutics

View the org chart displaying its 19 main executives

Most searched biographies at Elevar Therapeutics

• Saeho Chong, Chief Executive Officer and Director
• In Keun Jang, Director
• Yong-Hae Han, Director

Popular executive movements at Elevar Therapeutics

• Kenneth Rankin has joined the company as Vice President of Market Access  (posted on October 24 2023).
• Brian Cunningham has joined the company as Vice President of Sales  (posted on October 24 2023).
• Chris Galloway has joined the company as Vice President of Clinical Development  (posted on August 16 2023).

Create your alert
to follow the executive moves at Elevar Therapeutics.

Elevar Therapeutics has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Elevar Therapeutics

• LSKB announces initiation of a US clinical trial studying the dose escalation and safety of apatinib mesylate (YN968D1) in solid tumor cancers – Elevar Therapeutics
• News – Elevar Therapeutics
• News – Elevar Therapeutics

Social media about Elevar Therapeutics

• Elevar Therapeutics on Wikipedia, Google News & Yahoo Finance
• Elevar Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Saeho Chong

Call Elevar Therapeutics at +1 86...

View the org chart

Register to receive your alert

Report an error